Diagnostics & Tools February 2019

Crosstree BlueBooks provide an executive review of key health sciences transactions, financial movements, and public market activity. BlueBooks also offer a glimpse of how valuations are changing and how recent trends may affect future transactions.

• Transactions in the Diagnostics & Tools industry totaled eleven mergers & acquisitions and seventeen financings during the month of February
• In terms of M&A, Diagnostic Services was the most active this month, with 5 transactions; while in terms of financing, Life Science Tools was the most active, with 7 financings
• Total disclosed M&A value was $21.5 billion, while financings totaled $255.8 million
• The largest disclosed M&A transaction this month was the $21.0 billion acquisition of GE’s BioPharma business by Danaher, while the largest financing was $124 million raised by Burning Rock
• M&A and financings in the United States accounted for 73% and 53% of total transactions this month, down 7% and up 16%, respectively
• M&A activity this month includes acquisitions by Danaher, ICON plc, Discovery Life Sciences, BioMerieux, and Laboratory Corporation of America
• Crosstree acted as the exclusive financial advisor to MolecularMD on its strategic sale to ICON plc